(2021). Azithromycin/favipiravir/hydroxychloroquine: Lack of efficacy and off-label use: case report. Reactions Weekly.
Chicago Style Citation"Azithromycin/favipiravir/hydroxychloroquine: Lack of Efficacy and Off-label Use: Case Report." Reactions Weekly 2021.
Cita MLA"Azithromycin/favipiravir/hydroxychloroquine: Lack of Efficacy and Off-label Use: Case Report." Reactions Weekly 2021.
Atenció: Aquestes cites poden no estar 100% correctes.